The University of Chicago Header Logo

Connection

Mitchell C. Posner to Erlotinib Hydrochloride

Back to Details
This is a "connection" page, showing publications Mitchell C. Posner has written about Erlotinib Hydrochloride.
Mitchell C. Posner
Connection Strength
0.175
Erlotinib Hydrochloride
  1. Perioperative Gemcitabine?+?Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial. Ann Surg Oncol. 2019 Dec; 26(13):4489-4497.
    View in: PubMed
    Score: 0.175
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.